Try our beta test site
197 studies found for:    Galderma
Show Display Options
Rank Status Study
1 Completed A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: adapalene 0.1% and benzoyl peroxide 2.5% topical gel;   Drug: EPIDUO;   Drug: Placebo (Vehicle Gel)
2 Completed Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%;   Drug: Epiduo® Gel;   Drug: Placebo
3 Active, not recruiting Clinical Endpoint Study of Ivermectin 1% Cream
Condition: Moderate to Severe Papulopustular Rosacea
Interventions: Drug: Ivermectin Cream, 1%;   Drug: Placebo/Vehicle cream
4 Completed Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
Condition: Rosacea
Interventions: Drug: Brimonidine;   Drug: placebo
5 Completed
Has Results
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Adapalene/Benzoyl Peroxide;   Drug: Adapalene;   Drug: Benzoyl Peroxide;   Drug: Topical Gel Vehicle
6 Completed Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Adapalene;   Drug: Differin®;   Drug: Placebo
7 Completed Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
Condition: Acne Vulgaris
Intervention: Drug: adapalene 0.3% topical gel
8 Completed Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin
Condition: Photoaged Skin
Interventions: Procedure: Metvix PDT;   Procedure: placebo
9 Recruiting Safety and Efficacy of CD10367 in Psoriasis Vulgaris
Condition: Psoriasis Vulgaris
Interventions: Drug: CD10367 3% Solution - Non-desquamated zone;   Drug: CD10367 1% Solution - Non-desquamated zone;   Drug: CD10367 solution placebo - Non-desquamated zone;   Drug: Betneval ointment - Non-desquamated zone;   Drug: CD10367 3% Solution - Desquamated zone;   Drug: CD10367 solution placebo - Desquamated zone
10 Completed Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Adapalene/Benzoyl Peroxide
11 Recruiting Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
Condition: Psoriasis Vulgaris
Intervention: Drug: Calcitriol
12 Recruiting Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS
Condition: Keratosis, Actinic
Interventions: Device: Aktilite® Galderma;   Device: PHOS ISTOS PDT
13 Recruiting Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis
Condition: Psoriasis
Interventions: Drug: NP000888;   Drug: Vehicle
14 Recruiting Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
Condition: Keratosis, Actinic
Interventions: Device: FLEXITHERALIGHT PDT;   Device: Aktilite® Galderma
15 Completed
Has Results
Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris
Condition: Acne
Interventions: Drug: Adapalene BPO Gel standard daily overnight application;   Drug: Adapalene-BPO 3-hour daily application before bedtime;   Drug: Adapalene-BPO Gel every other day application;   Drug: Adapalene-BPO Gel standard+Cetaphil® Moisturizing Lotion
16 Completed
Has Results
Anesthetic Effect Duration Assessment
Condition: Healthy Volunteers
Intervention: Drug: Lidocaine 7% + Tetracaine 7% cream
17 Completed
Has Results
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
Condition: Acne Vulgaris
Intervention: Drug: Adapalene
18 Completed Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Adapalene-BPO Gel
19 Completed Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Clobetasol Propionate, 0.05%;   Drug: Calcipotriene and betamethasone dipropionate ointment
20 Completed Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: Clobetasol Propionate, 0.05%;   Drug: Clobetasol propionate, 0.05% Spray

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.